Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01160211 |
|---|---|
| Brief Title: | A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer |
| First Submitted : | July 1, 2010 |
| First Submitted that Met QC Criteria : | July 8, 2010 |
| First Posted : | July 12, 2010 (Estimate) |
| Results First Submitted : | January 3, 2019 |
| Results First Submitted that Met QC Criteria : | May 1, 2019 |
| Results First Posted : | July 15, 2019 |
| Last Update Submitted that Met QC Criteria : | June 10, 2022 |
| Last Update Posted : | June 30, 2022 |